Luminex logo

LMNX - Luminex News Story

$36.84 -0.0  -0.1%

Last Trade - 6:45pm

Sector
Healthcare
Size
Mid Cap
Market Cap £1.24bn
Enterprise Value £1.16bn
Revenue £302.9m
Position in Universe 2366th / 6854

BRIEF-Luminex Receives FDA Emergency Use Authorization And CE Mark For Expanded NxTAG Respiratory Panel Test Including Sars-Cov-2

Thu 4th March, 2021 11:41am
March 4 (Reuters) - Luminex Corp  LMNX.O :
    * LUMINEX RECEIVES FDA EMERGENCY USE AUTHORIZATION AND CE
MARK FOR
EXPANDED NXTAG® RESPIRATORY PANEL TEST INCLUDING SARS-COV-2

Source text for Eikon:  ID:nPn6LhdWwa 
Further company coverage:  LMNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.